BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33835351)

  • 1. Analysis of Anti-Doping Rule Violations That Have Impacted Medal Results at the Summer Olympic Games 1968-2012.
    Kolliari-Turner A; Lima G; Hamilton B; Pitsiladis Y; Guppy FM
    Sports Med; 2021 Oct; 51(10):2221-2229. PubMed ID: 33835351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping practices in international weightlifting: analysis of sanctioned athletes/support personnel from 2008 to 2019 and retesting of samples from the 2008 and 2012 Olympic Games.
    Kolliari-Turner A; Oliver B; Lima G; Mills JP; Wang G; Pitsiladis Y; Guppy FM
    Sports Med Open; 2021 Jan; 7(1):4. PubMed ID: 33415428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A; Healy D
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisation.
    Lauritzen F; Holden G
    Drug Test Anal; 2023 May; 15(5):506-515. PubMed ID: 36582051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Doping Prevalence and Socioeconomic Parameters: An Analysis by Sport Categories and World Areas.
    Terreros JL; Manonelles P; López-Plaza D
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping in the Ultimate Fighting Championship (UFC): A 4-year epidemiological analysis.
    Fares MY; Baydoun H; Salhab HA; Khachfe HH; Fares Y; Fares J; Abboud JA
    Drug Test Anal; 2021 Apr; 13(4):785-793. PubMed ID: 33270353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.
    Sobolevsky T; Krotov G; Dikunets M; Nikitina M; Mochalova E; Rodchenkov G
    Drug Test Anal; 2014; 6(11-12):1087-101. PubMed ID: 25312500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of doping in sports: doping control in Norway, 1977-1995.
    Bahr R; Tjørnhom M
    Clin J Sport Med; 1998 Jan; 8(1):32-7. PubMed ID: 9448955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug testing at the 10th Asian Games and 24th Seoul Olympic Games.
    Park J; Park S; Lho D; Choo HP; Chung B; Yoon C; Min H; Choi MJ
    J Anal Toxicol; 1990; 14(2):66-72. PubMed ID: 2325381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olympic anti-doping laboratory: the analytical technological road from 2016 Rio De Janeiro to 2021 Tokyo.
    Saad K; Salama S; Horvatovich P; Al Maadheed M; Georgakopoulos C
    Bioanalysis; 2021 Oct; 13(19):1511-1527. PubMed ID: 34617444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating?
    Mottram DR
    Sports Med; 1999 Jan; 27(1):1-10. PubMed ID: 10028129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of high-level Spanish athletes in the Olympic Games according to gender.
    Leiva-Arcas A; Vaquero-Cristóbal R; Abenza-Cano L; Sánchez-Pato A
    PLoS One; 2021; 16(5):e0251267. PubMed ID: 33956856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H; Auchus RJ
    Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.